The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic.

Autor:	Crawford JM; Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA., Aguero-Rosenfeld ME; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA., Aifantis I; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA., Cadoff EM; Department of Pathology, Montefiore Medical Center, Bronx, NY, USA., Cangiarella JF; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA., Cordon-Cardo C; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, NY, USA., Cushing M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Firpo-Betancourt A; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, NY, USA., Fox AS; Department of Pathology, Montefiore Medical Center, Bronx, NY, USA., Furuya Y; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Hacking S; Department of Pathology and Laboratory Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA., Jhang J; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, NY, USA., Leonard DGB; Department of Pathology and Laboratory Medicine, Robert Larner MD College of Medicine, University of Vermont, Burlington, VT, USA., Libien J; Department of Pathology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA., Mendu DR; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine, Mount Sinai Health System, New York, NY, USA., Mulligan MJ; Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA., Nasr MR; Department of Pathology, Upstate Medical University, Syracuse, NY, USA., Pecora ND; Department of Pathology and Laboratory Medicine, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA., Pessin MS; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Prystowsky MB; Department of Pathology, Montefiore Medical Center, Bronx, NY, USA., Ramanathan LV; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rauch KR; Hospital Association of New York, Renssaeler, NY, USA., Riddell S; Department of Pathology, Upstate Medical University, Syracuse, NY, USA., Roach K; Hospital Association of New York, Renssaeler, NY, USA., Roth KA; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Shroyer KR; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA., Smoller BR; Department of Pathology and Laboratory Medicine, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA., Spitalnik SL; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Spitzer ED; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA., Tomaszewski JE; Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, in partnership with Kaleida Health Laboratories, Buffalo, NY, USA., Waltman S; Greater New York Hospital Association, New York, NY, USA., Willis L; Hospital Association of New York, Renssaeler, NY, USA., Sumer-King Z; Greater New York Hospital Association, New York, NY, USA.
Jazyk:	angličtina
Zdroj:	Academic pathology [Acad Pathol] 2021 May 07; Vol. 8, pp. 23742895211006818. Date of Electronic Publication: 2021 May 07 (Print Publication: 2021).
DOI:	10.1177/23742895211006818
Abstrakt:	The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, created an unprecedented need for comprehensive laboratory testing of populations, in order to meet the needs of medical practice and to guide the management and functioning of our society. With the greater New York metropolitan area as an epicenter of this pandemic beginning in March 2020, a consortium of laboratory leaders from the assembled New York academic medical institutions was formed to help identify and solve the challenges of deploying testing. This report brings forward the experience of this consortium, based on the real-world challenges which we encountered in testing patients and in supporting the recovery effort to reestablish the health care workplace. In coordination with the Greater New York Hospital Association and with the public health laboratory of New York State, this consortium communicated with state leadership to help inform public decision-making addressing the crisis. Through the length of the pandemic, the consortium has been a critical mechanism for sharing experience and best practices in dealing with issues including the following: instrument platforms, sample sources, test performance, pre- and post-analytical issues, supply chain, institutional testing capacity, pooled testing, biospecimen science, and research. The consortium also has been a mechanism for staying abreast of state and municipal policies and initiatives, and their impact on institutional and laboratory operations. The experience of this consortium may be of value to current and future laboratory professionals and policy-makers alike, in dealing with major events that impact regional laboratory services. Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2021.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu